concentrations are associated with aortic stiffness and wave reflection independent of either brachial office or ambulatory BP and other confounders.
Methods

Study Group
The present study was conducted according to the principles outlined in the Helsinki declaration. The Committee for Research on Human Subjects of the University of the Witwatersrand approved the protocol (approval number: M02-04-72 renewed as M07-04-69 and M12-04-108). Participants provided informed, written consent. All participants were part of a community-based study previously described. [18] [19] [20] Briefly, nuclear families of black African descent, with siblings >16 years of age were randomly recruited from the South West Township of Johannesburg, South Africa. Of the 1211 participant recruited, all central aortic hemodynamic assessments were available in 966 participants. Aortic pulse wave velocity (PWV) could not be accurately ascertained in 170 overweight or obese participants because of an inability to obtain carotid or femoral pulse waveforms, and wave separation analysis was not possible in 75 participants.
Clinical, Demographic, and Anthropometric Variables
A standardized questionnaire was used to obtain demographic information, a clinical history, and a history of smoking and alcohol intake of the participants. [18] [19] [20] Height and weight, for the determination of body mass index, were measured using standard methods, and participants were defined as obese if their body mass index was >30 kg/m 2 . Laboratory blood tests for total, high-density lipoprotein, and low-density lipoprotein cholesterol concentrations, percent glycohemoglobin, and creatinine concentrations were performed. Diabetes mellitus was defined as the presence of glucose lowering therapy or a glycohemoglobin value >6.1%. Estimated glomerular filtration rate (eGFR) was determined using the abbreviated Modification of Diet in Renal Disease study group equation: 186.3×(serum creatinine in mg/decilitre −1.154 )×(age in years −0.203 )×1.212×0.742 (if female).
Blood Pressure
Nurse-derived conventional BP was measured after 10 minutes of rest in the seated position as previously described 18 within a half hour of obtaining blood samples and in the opposite arm to that subjected to venesection. These measurements were obtained by a trained nurse using a mercury sphygmomanometer and an appropriate sized cuff according to the European Society of Hypertension guidelines. 21 Five consecutive BP readings were obtained 30 to 60 seconds apart. The average of the 5 readings was taken as the BP. Only 0.31% of visits had fewer than the planned BP recordings. The frequency of identical consecutive recordings was 0.31% for systolic BP (SBP) and 1.24% for diastolic BP (DBP). No BP values were recorded as an odd number. Of the SBP and DBP readings, 30.6% ended on a zero (expected=20%). Hypertension was diagnosed as the presence of antihypertensive therapy or a conventional BP≥140/90 mm Hg.
Ambulatory 24-hour, day and night BP were determined using SpaceLabs monitors (model 90207; Spacelabs, Redmond, Washington) as previously described. 18 The size of the cuff was the same as that used for conventional BP measurements. Monitors were programmed to measure 24-hour BP at 15-minute intervals from 06:00 to 22:00 hours and at 30-minute intervals from 22:00 to 06:00 hours. Intraindividual means of the ambulatory measurements were weighted by the time interval between successive readings. 18 The average (±SD) number of BP readings obtained was 60.8±12.1 (range=24-81) for the 24-hour period.
Galectin-3 and C-Reactive Protein Concentrations
Blood samples were centrifuged and immediately stored at −80°C. Plasma concentrations of human galectin-3 were measured using an enzyme-linked immunosorbent assay (Quantikine; R&D Systems Inc, Minneapolis, MN) with a lower detection limit of 0.016 ng/mL and intra-assay and interassay coefficients of variation ranging from 3.5% to 4.3% and 5.8% to 6.0%, respectively. Serum high sensitivity C-reactive protein (CRP) concentrations (range 0.01-50 ng/mL) were measured using an enzyme-linked immunosorbent assay (Quantikine) with a mean lower detection limit of 0.010 ng/mL and intra-assay and interassay coefficients of variation ranging from 3.8% to 8.3% and 6.0% to 7.0%, respectively. CRP concentrations could not be determined on 22 participants whose concentrations were below the lower level of detection.
Central Aortic Hemodynamics
Central aortic hemodynamics were determined as previously described. [18] [19] [20] 22 After participants had rested for 15 minutes in the supine position, arterial waveforms at the radial (dominant arm), carotid, and femoral artery pulses were recorded by applanation tonometry. Pressure waveforms were recorded during an 8-second period using a high-fidelity SPC-301 micromanometer (Millar Instrument, Inc, Houston, TX) interfaced with a computer using SphygmoCor, version 9.0 software (AtCor Medical Pty. Ltd., West Ryde, New South Wales, Australia). Aortic PWV was determined from sequential waveform measurements at carotid and femoral sites as previously described. 22 The time delay in the pulse waves between the carotid and femoral sites was determined using an ECG-derived R wave as a fiducial point. Pulse transit time was taken as the average of 10 consecutive beats. The distance which the pulse wave travels was determined as the difference between the distance from the femoral sampling site to the suprasternal notch and the distance from the carotid sampling site to the suprasternal notch. Aortic PWV was calculated as the ratio of the distance to the transit time (m/s).
To determine aortic wave reflection and aortic BP, the pulse wave obtained from the radial tonometer recordings was calibrated by manual measurement (auscultation) of brachial BP taken immediately before the recordings. The radial pressure waveform was converted into a central (aortic) waveform using a validated generalized transfer function incorporated in SphymoCor software. The aortic backward (reflected; Pb) and the aortic forward (Pf) wave pressures were determined from the aortic pulse wave using SphygmoCor software, which separates the aortic waveform using a triangular flow wave. 23 Reflected wave index (RI) was calculated as Pb/(Pf+Pb), as previously described, 12 and as Pb/Pf. 13 Central aortic SBP was derived from the aortic waveform and central aortic pulse pressure (PP) was calculated from the difference between central SBP and central DBP. All measurements were made by a single experienced trained technician unaware of the clinical history of the participants and with a low degree of intraobserver variability and a high degree of reproducibility. 19, 20 
Statistical Analysis
Statistical analysis was conducted using SAS software, version 9.3 (SAS Institute Inc, Cary, NC). Data are presented as mean±SD. As galectin-3 concentrations were positively skewed (skewness=2.06; kurtosis=9.37, Shapiro-Wilk's statistics =0.87), they were log transformed, which improved the distribution of the data (skew-ness=−0.25; kurtosis=1.53, Shapiro-Wilk's statistics =0.99). As aortic PWV was positively skewed (skewness=1.79; kurtosis=5.38, Shapiro-Wilk's statistics =0.87), it was similarly log transformed, which improved the distribution of the data (skewness=0.03; kurto-sis=1.46, Shapiro-Wilk's statistics =0.98). Hence, all analyses were conducted on log-transformed galectin-3 concentrations and logtransformed PWV. Multivariate regression analysis was performed to determine independent relationships. Factors included in multivariate models were those associated with galectin-3 on bivariate analysis, and pulse rate, regular smoking, and regular alcohol were forced into the models because of their relations with central hemodynamics. Because antihypertensive therapy may affect aortic PWV, sensitivity analysis was also conducted in participants having never received antihypertensive therapy. Table 1 shows the characteristics of the participants in the study sample. More women than men participated. A high proportion of participants had hypertension, which had never been treated with antihypertensive therapy (56%). Marginally, more participants without all central aortic hemodynamic characteristics were women, and these participants tended to be slightly older, have a higher body mass index, a higher proportion were obese, and they had higher mean cholesterol concentrations and lower eGFR values (Table 1) . Importantly, however, no differences were noted in brachial or aortic hemodynamic characteristics or in circulating galectin-3 concentrations in participants with and without all central aortic hemodynamic assessments (Table 1 ).
Results
Participant Characteristics
Demographic and Clinical Factors Associated With Plasma Galectin-3 Concentrations
On bivariate analysis, plasma galectin-3 concentrations were correlated with age, body mass index, office SBP, treatment for hypertension, diabetes mellitus or a glycohemoglobin >6.1%, and total and low-density lipoprotein cholesterol concentrations, as well as eGFR ( Table 2 ). In addition, weak correlations were noted between galectin-3 concentrations and female sex, and a trend for a relationship was noted with smoking (Table 2 ). However, neither office DBP, 24-hour SBP or DBP, pulse rate nor regular alcohol intake was correlated with galectin-3 concentrations ( Table 2 ). In multivariate stepwise regression models with conventional SBP, but not DBP or 24-hour BP, and all of the aforementioned factors included in the models, age, female gender, total cholesterol concentrations, and a trend for eGFR were independently associated with galectin-3 concentrations (Table 2) . Importantly, office Table 2 ).
Associations of Plasma Galectin-3 Concentrations With Aortic PWV
On bivariate analysis and in multivariate models, including adjustments for brachial office or 24-hour mean arterial pressure (MAP; distending pressures), PP, or SBP in separate models, plasma galectin-3 concentrations were associated with aortic PWV (Table 3) . These relationships were also noted in both women and in men with adjustments for brachial office MAP, in women with adjustments for brachial office PP or SBP in separate models (Table 3) , and in women with adjustments for 24-hour brachial MAP, PP, or SBP in separate models ( Table S1 in the online-only Data Supplement). Multivariate adjusted aortic PWV increased across octiles of galectin-3 concentrations, and these effects were independent of either brachial office or 24-hour MAP or SBP in separate models ( Figure 1 ). As compared with the lowest 3 octiles of galectin-3 concentrations, the highest 4 octiles of galectin-3 concentrations were associated with higher multivariate adjusted aortic PWV values ( Figure 1 ). The independent relationships between galectin-3 concentrations and aortic PWV were reproduced in sensitivity analysis conducted in participants not receiving antihypertensive therapy ( Table 3 ).
Associations of Plasma Galectin-3 Concentrations With Aortic Reflected Wave and Aortic BP
On bivariate analysis, plasma galectin-3 concentrations were correlated with RI and central aortic PP (Table 4 ). In multivariate models, with adjustments for brachial office or 24-hour MAP or SBP, plasma galectin-3 concentrations were independently associated with RI in men, but not in women (Table 4 and Figure 2 ; Table S2 ). The MAP-independent relations between galectin-3 concentrations and RI in men were reproduced in sensitivity analysis conducted in participants not receiving antihypertensive therapy (partial r=0.15, confidence interval [CI]=0.03-0.25, P<0.02). Brachial office MAP-independent relations were noted between galectin-3 concentrations and central aortic PP, findings reproduced in sensitivity analysis conducted in participants not receiving antihypertensive therapy and in both women and men (trend effect; Table 4 ). However, we were statistically underpowered to show a brachial 24-hour MAP-independent relation between galectin-3 concentrations and central aortic PP in participants not receiving antihypertensive therapy (data not shown). Table S3 ). 
Associations of Plasma Galectin-3 Concentrations With Aortic PWV and Reflected Waves Are Independent of CRP
Discussion
The main findings of the present study are as follows: In a large randomly selected community-based study, we show that despite a lack of independent association between plasma galectin-3 concentrations and either office or ambulatory brachial BP, circulating galectin-3 concentrations were independently associated with aortic PWV in all participants and with RI in men. Moreover, the relations between galectin-3 concentrations and aortic hemodynamics were independent of the inflammatory marker CRP.
Prior studies suggest that galectin-3 contributes toward the development of 5 and outcomes in 3 heart failure, presumably through direct effects on the myocardium. However, galectin-3 also predicts all-cause mortality in the general population. 4, 5 Whether the relationship with all-cause mortality is explained only through an effect on heart failure or, in addition, by associations with other cardiovascular events is unknown. In this regard, we show that galectin-3 concentrations are associated with carotid-femoral (aortic) PWV (aortic stiffness), independent of conventional cardiovascular risk factors. As aortic PWV predicts general cardiovascular outcomes, 6,7 including stroke and myocardial infarction, 7 independent of conventional risk factors, galectin-3 may ultimately translate into total mortality through an effect on aortic stiffness.
In the present study, no independent relationship was noted between galectin-3 concentrations and brachial BP. This is in contrast to the age and sex-adjusted relationships between galectin-3 and brachial BP 4 or hypertension 5 previously described. Hence, unlike previous studies which could not exclude the possibility that galectin-3 predicts all-cause mortality in-part because of associations with brachial BP, 4,5 the present study suggests that relationships between galectin-3 and aortic stiffness are not accounted for by relations between brachial BP and large vessel dysfunction. The apparent discrepancy in the present versus prior 4,5 studies demonstrating relationships between circulating galectin-3 concentrations and BP warrant consideration. In one study, 5 although galectin-3 was associated with hypertension, no significant relationship was noted with office (brachial) BP. In the other study, 4 galectin-3 relationships with BP were not assessed in multivariate models with all comorbidities that correlated with galectin-3 concentrations included in the model. In this regard, in that study, 4 galectin-3 concentrations were also associated with indexes of an excess adiposity, a well-recognized cause of increases in BP. Importantly, unlike in the present study where the lack of independent relationships between galectin-3 and brachial BP were confirmed with ambulatory BP monitoring, in prior studies, 4,5 relationships between galectin-3 and either the presence of hypertension or brachial BP relied on office BP measurements only.
In the present study, the independent relationship between galectin-3 and aortic PWV appeared to translate into modest associations with RI in men, but not in women, but with increases in aortic pulse pressure in women and men. In this regard, aortic reflected waves [12] [13] [14] have been demonstrated to be predictors of cardiovascular outcomes beyond brachial BP. In women, however, increases in aortic pulse pressure, but not RI, may be mediated through aortic stiffness-induced increases in both forward and backward wave pressures. In these circumstances, although aortic pressures increase, RI, which is expressed as a ratio of backward-to-forward wave pressures, may not increase. Alternatively, independent of reflected wave effects or aortic pressures, galectin-3-induced increases in aortic PWV may mediate adverse cardiovascular effects through facilitation of transmission of pulsatile energy into end-organ circulatory systems. 15 Hence, the effect of galectin-3 on aortic stiffness may mediate adverse cardiovascular actions through an action that is independent of both brachial and aortic-BP.
Galectin-3 is released from macrophages and stimulates fibroblasts to produce tissue fibrosis and remodeling. 1, 2 Galectin-3 is expressed in a variety of tissues, 1,2 including in human atherosclerotic lesions, 16 and mediates aldosteroneinduced vascular fibrosis. 17 It is therefore possible that galectin-3 may be overexpressed in aortic atherosclerotic lesions, an effect which through fibrosis translates into increases in aortic stiffness. Importantly, although in the present study, galectin-3 concentrations were independently associated with cholesterol concentrations, cholesterol was not independently and positively correlated with aortic hemodynamics, and the galectin-3 versus aortic hemodynamic relationships were independent of cholesterol. Further studies are warranted to explore the possibility that galectin-3 contributes to increases in aortic stiffness and reflected waves through profibrotic effects and to determine whether these effects occur through actions in atherosclerotic regions alone.
In keeping with previous studies, 4, 5 we show an inverse relationship between galectin-3 and eGFR. In this regard, galectin-3 may mediate renal dysfunction by promoting renal fibrosis. 24 However, in the present study, relations between galectin-3 concentrations and eGFR were not independent of confounders, and galectin-3 concentrations were associated with aortic hemodynamics independent of confounders, as well as eGFR. Hence, it is unlikely that the associations between galectin-3 concentrations and aortic hemodynamics can be attributed to the adverse effects of renal dysfunction.
The limitations of the present study warrant consideration. We cannot exclude the possibility of residual confounding effects or whether the associations between galectin-3 and aortic PWV or reflected waves represent reverse causality. In this regard, increases in aortic stiffness may reflect the extent of atherosclerosis, and atherosclerotic lesions may be the source of circulating galectin-3. 16 Further studies are therefore required to determine whether interventions that specifically reduce galectin-3 concentrations, which to the best of our knowledge are not presently available, are independently associated with decreases in aortic stiffness. Second, the present study was conducted in a group of black African ancestry, and hence, the present results require validation in alternative ethnic groups. Third, PWV measurements were obtained from pulse transit distance using subtracted distances (difference between the distance from the femoral sampling site to the suprasternal notch and the distance from the carotid sampling site to the suprasternal notch) before the recommendation that a standardized approach of 80% of the direct carotid-femoral distance be used. 25 Hence, our PWV values may be marginally different from actual invasive measurements. Fourth, a bias toward office BP measurements ending with a zero was noted. Hence, galectin-3 relations with aortic pressures may have been over-or underestimated. However, the relations between galectin-3 and the main outcome measures (aortic PWV or the reflected wave index) are not subject to errors in BP measurement. Fifth, although office and 24-hour brachial MAP-, PP-, and SBP-independent relations between galectin-3 concentrations and PWV were noted in women and office brachial MAP-independent relations between galectin-3 concentrations and PWV were noted in men, we were not statistically powered to show office brachial PP-and SBP-independent relations or 24-hour MAP-independent relations between galectin-3 concentrations and PWV in men. Hence, further work is required to determine whether the effects of galectin-3 concentrations on aortic stiffness and wave reflection are sexspecific. Last, aortic pressure wave separation was performed using a triangular flow waveform rather than a measured or physiological aortic flow waveform, and hence, RI should be considered as an approximate at best.
Perspectives
Recent evidence suggests that the profibrotic inflammatory substance galectin-3 predicts all-cause mortality in the general population. 4, 5 Although this is assumed to be through direct effects on the myocardium promoting the development of heart failure, 3 it is uncertain whether these actions are attributed in-part to associations with traditional risk factors, including BP, 4, 5 or whether alternative actions of galectin-3 on large 16, 17 may also contribute toward the ability of galectin-3 to predict cardiovascular outcomes. The present study suggests that galectin-3 may contribute toward adverse cardiovascular effects in-part through an effect on aortic stiffness and in men at least on wave reflection, effects which cannot be attributed to associations with brachial BP or to generalized inflammation. *Adjustments are for age, BP as indicated in separate models, pulse rate, body mass index, regular smoking, regular alcohol intake, diabetes mellitus or an HbA1c>6.1%, total cholesterol, treatment for hypertension and estimated glomerular filtration rate.
Probability values are further adjusted for non-independence of family members.
